CCL13 and epilepsy: Among the genes that were highly expressed in the epileptic group, we found RCHY1, CCL13, LAIR-1, RPSAP58, IL6R, CCDC14, AFAP1L2, TRIM24, CSMD1, ZNF704, CDK5RAP3, FRAS1, SKA1, CYS1, IL5, LHFP and CPB1. Interestingly, VPA treatment reduced their expression, suggesting that these genes promote epilepsy, since this condition was also diminished as the treatment period progressed.